Global Tumor Genomics Market (2019 to 2028) - Growing Prominence for Precision Medicine Presents Lucrative Opportunities - ResearchAndMarkets.com

DUBLIN--()--The "Global Tumor Genomics Market: Focus on Products, Techniques, Applications, End User, Cancer Type, 14 Countries Data, Industry Insights and Competitive Landscape - Analysis and Forecast, 2019-2028" report has been added to ResearchAndMarkets.com's offering.

According to this report the global tumor genomics market generated a revenue of $8,131.0 million in 2019 and is estimated to grow over $16,287.2 million by the end of 2028.

The market is projected to grow at a CAGR of 8.09%, during the forecast period from 2020 to 2028. There are multiple factors that drive the tumor genomics market such as rising government initiatives, increasing number of product approvals and launches, and rising incidence cases of cancer, thus increasing the utilization of genomic techniques (such as next-generation techniques, polymerase chain reaction, microarray, in-situ hybridization, immunohistochemistry). Moreover, there are challenges that hamper the growth of the tumor genomics market including the high cost of genomic equipment, and lack of unified framework for data integration.

The report provides varied segmentation of the market done on the basis of products, techniques, application, end user, cancer type, and region. On the basis of product type the market has been segmented into assays and kits, and instruments. Likewise, on the basis of techniques, the market has been divided into next-generation sequencing, polymerase chain reaction, microarray, in-situ hybridization, immunohistochemistry, and others (mass spectrometry and flow cytometry).

Moreover, the market is also categorized on the basis of application (diagnostics and monitoring, drug discovery and development, and biomarker discovery), and on the basis of end user (academics and research organizations, hospitals and ambulatory clinics, clinical and diagnostic laboratories, and biotechnology and pharmaceutical company). The market is further categorized on the basis of cancer type (prostate cancer, breast cancer, lung cancer, melanoma, lung cancer, colon cancer, head and neck cancer, and others {ovarian, pancreatic, and testicular cancer}). Several established leading companies and start-ups are based out of the developed regions as well as developing regions, such as North America, Europe, and Asia-Pacific, and Latin America.

Market Dynamics

Drivers

  • Rising Government Initiatives and Projects
  • Increasing Incidence of Cancer
  • Increasing Number of Product Approvals and Launches
  • Ever-Expanding Application Areas for Genomics
  • Increasing Use of Biomarkers in Cancer Profiling

Challenges

  • High Cost of Genomic Equipment
  • Lack of Unified Framework for Data Integration

Opportunities

  • Growing Prominence for Precision Medicine
  • Increasing Demand for Point-of-Care Diagnostics

Key Questions Answered:

  1. What is tumor genomics? How different tumor genomic techniques have evolved over the years?
  2. What are the major market drivers, challenges, and opportunities in the global tumor genomics market?
  3. What was the global tumor genomics market size in terms of revenue in 2019? How is the market expected to evolve in the upcoming years? What is the market size expected to be in 2028?
  4. How is each segment of the global tumor genomics market expected to grow during the forecast period between 2020 to 2028 and what is the revenue expected to be generated by each of the segments by the end of 2028?
  5. What are the developmental strategies implemented by the key players to sustain in the competitive market?
  6. What is the growth potential of the tumor genomics market in each region, namely, North America, Europe, Asia-Pacific, and the Rest-of-the-World?
  7. Which product among the two (assays and kits & instrument) are offered by key players such as Thermo Fisher Scientific, Illumina Inc., Qiagen N.V., and F. Hoffmann-La Roche Ltd.?
  8. Which technique is leading the market in 2018 and expected to dominate the market in 2028 and why?
  9. Which application and end user type are leading the market in 2019 and are expected to dominate the market in 2028 and why?
  10. Which region dominated the global tumor genomics market in 2019 and what are the expected trends from each of the regions in the forecast period 2020-2028?

Companies Mentioned

  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd
  • Fluidigm Corporation
  • General Electric Company
  • Illumina, Inc.
  • Merck KGaA
  • Myriad Genetics, Inc.
  • Pacific Biosciences of California, Inc.
  • PerkinElmer
  • QIAGEN
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.

For more information about this report visit https://www.researchandmarkets.com/r/uakbx5

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900